Cristina Marchini Selected Research

Cristina Marchini Research Topics

Disease

29	Neoplasms (Cancer) 01/2024 - 05/2005
20	Breast Neoplasms (Breast Cancer) 01/2024 - 11/2010
7	Carcinogenesis 11/2020 - 04/2011
3	Carcinoma (Carcinomatosis) 01/2019 - 11/2010
2	Neoplasm Metastasis (Metastasis) 01/2024 - 11/2010
2	Triple Negative Breast Neoplasms 01/2021 - 01/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2022
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2010
6	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 06/2011
4	DNA VaccinesIBA 08/2022 - 04/2010
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2022 - 04/2010
3	GoldIBA 01/2022 - 07/2018
2	Lipid NanoparticlesIBA 12/2022 - 08/2021
2	Messenger RNA (mRNA)IBA 12/2022 - 12/2019
2	Cancer VaccinesIBA 12/2022 - 01/2013
2	Protein CoronaIBA 09/2022 - 01/2016
2	human ERBB2 proteinIBA 09/2022 - 11/2020
2	Trastuzumab (Herceptin)FDA Link 08/2022 - 01/2013
2	Oncogene Proteins (Oncogene Protein)IBA 08/2022 - 04/2011
2	LigandsIBA 01/2022 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 07/2018
2	RutheniumIBA 01/2021 - 01/2016
2	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 11/2020 - 08/2014
2	phosphine (phosphane)IBA 01/2020 - 07/2018
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2017
2	Protein Isoforms (Isoforms)IBA 12/2018 - 10/2016
2	ResveratrolIBA 01/2018 - 01/2017
1	Glycoproteins (Glycoprotein)IBA 01/2024
1	SirtuinsIBA 12/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2023
1	RNA (Ribonucleic Acid)IBA 12/2022
1	Small Interfering RNA (siRNA)IBA 12/2022
1	COVID-19 VaccinesIBA 12/2022
1	graphene oxideIBA 09/2022
1	VaccinesIBA 08/2022
1	AntibodiesIBA 08/2022
1	MetalsIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Benzoates (Benzoate)IBA 01/2022
1	Gold CompoundsIBA 01/2022
1	imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 11/2020
1	acetylshikoninIBA 11/2020
1	NaphthoquinonesIBA 11/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	AzolesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 12/2019
1	Glu Transfer RNAIBA 12/2019
1	NucleolinIBA 12/2019
1	StathminIBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2018
1	Deubiquitinating EnzymesIBA 07/2018
1	Fluorouracil (Carac)FDA LinkGeneric 10/2017
1	3,7,11,15- tetramethyl- 1,2,3- hexadecanetriolIBA 10/2017
1	SolutionsIBA 10/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2017
1	CarcinogensIBA 01/2017
1	Drinking WaterIBA 01/2017
1	Phytoestrogens (Phytoestrogen)IBA 01/2017
1	Proteasome InhibitorsIBA 01/2017
1	dacomitinibIBA 10/2016
1	saracatinibIBA 10/2016
1	Lapatinib (GW572016)FDA Link 10/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2016
1	Organometallic CompoundsIBA 01/2016
1	4-cymene (p-cymene)IBA 01/2016
1	Liposomes (Liposome)IBA 01/2016
1	polyacrylamideIBA 01/2016
1	liposomal amphotericin B FDA Link 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Ruthenium CompoundsIBA 01/2016
1	Immunoglobulin A (IgA)IBA 01/2016
1	Blood Proteins (Serum Proteins)IBA 01/2016
1	AutoantibodiesIBA 01/2016
1	PlatinumIBA 01/2016
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 01/2016
1	AntigensIBA 01/2015
1	sanguinarineIBA 08/2014
1	PerforinIBA 06/2014
1	InterleukinsIBA 06/2014
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 02/2014
1	dorsomorphinIBA 02/2014
1	EpitopesIBA 01/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2012
1	ElementsIBA 10/2012
1	LipidsIBA 06/2011
1	PropaneIBA 06/2011
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 06/2011
1	Firefly LuciferasesIBA 04/2011
1	LuciferasesIBA 04/2011

Therapy/Procedure

8	Therapeutics 01/2022 - 11/2010
3	Immunotherapy 08/2021 - 01/2013
1	Drug Therapy (Chemotherapy) 01/2021
1	Oral Administration 08/2014